Search research articles
Contact Us
Filters
Showing results (111-120 of 154) with videos related to
Page
of 16
Sort By:
Cancer Letters
|
February 21, 2021
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair
Silvia Codenotti, Francesco Marampon, Luca Triggiani, et al.
Cancers
|
November 26, 2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
Silvia Sideri, Francesco Petragnano, Roberto Maggio, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals
Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, et al.
Radiation Oncology Journal
|
February 10, 2025
Reducing clinical target volume margins for multifocal glioblastoma: a multi-institutional analysis of patterns of recurrence and treatment response
Francesco Marampon, Giovanni Luca Gravina, Elisa Cinelli, et al.
Cancer Letters
|
March 27, 2017
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
Francesco Marampon, Francesca Megiorni, Simona Camero, et al.
International Journal of Oncology
|
November 6, 2013
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines
Francesco Marampon, Giovanni Luca Gravina, Valdimir M Popov, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis
Letizia Ferella, Erika Limoncin, Francesca Vittorini, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties
Alessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Journal of Cancer Research and Clinical Oncology
|
July 27, 2019
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
Francesco Marampon, Flavio Leoni, Andrea Mancini, et al.
Brain Sciences
|
July 29, 2025
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide
Paolo Tini, Flavio Donnini, Francesco Marampon, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 154) with videos related to
Sort By:
Page
of 16
Cancer Letters
|
February 21, 2021
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair
Silvia Codenotti, Francesco Marampon, Luca Triggiani, et al.
Cancers
|
November 26, 2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
Silvia Sideri, Francesco Petragnano, Roberto Maggio, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals
Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, et al.
Radiation Oncology Journal
|
February 10, 2025
Reducing clinical target volume margins for multifocal glioblastoma: a multi-institutional analysis of patterns of recurrence and treatment response
Francesco Marampon, Giovanni Luca Gravina, Elisa Cinelli, et al.
Cancer Letters
|
March 27, 2017
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
Francesco Marampon, Francesca Megiorni, Simona Camero, et al.
International Journal of Oncology
|
November 6, 2013
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines
Francesco Marampon, Giovanni Luca Gravina, Valdimir M Popov, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis
Letizia Ferella, Erika Limoncin, Francesca Vittorini, et al.
Frontiers in Pharmacology
|
October 5, 2020
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties
Alessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Journal of Cancer Research and Clinical Oncology
|
July 27, 2019
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
Francesco Marampon, Flavio Leoni, Andrea Mancini, et al.
Brain Sciences
|
July 29, 2025
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide
Paolo Tini, Flavio Donnini, Francesco Marampon, et al.
Page
of 16